Renal Division, Ghent University Hospital, Ghent, Belgium.
Medical Clinic V, Nephrology, Hypertension and Blood Purification, Academic Teaching Hospital Braunschweig, Braunschweig, Germany.
Lancet. 2017 May 27;389(10084):2139-2151. doi: 10.1016/S0140-6736(17)31329-6.
Acute kidney injury (AKI) is a multifaceted syndrome that occurs in different settings. The course of AKI can be variable, from single hit and complete recovery, to multiple hits resulting in end-stage renal disease. No interventions to improve outcomes of established AKI have yet been developed, so prevention and early diagnosis are key. Awareness campaigns and education for health-care professionals on diagnosis and management of AKI-with attention to avoidance of volume depletion, hypotension, and nephrotoxic interventions-coupled with electronic early warning systems where available can improve outcomes. Biomarker-based strategies have not shown improvements in outcome. Fluid management should aim for early, rapid restoration of circulatory volume, but should be more limited after the first 24-48 h to avoid volume overload. Use of balanced crystalloid solutions versus normal saline remains controversial. Renal replacement therapy should only be started on the basis of hard criteria, but should not be delayed when criteria are met. On the basis of recent evidence, the risk of contrast-induced AKI might be overestimated for many conditions.
急性肾损伤(AKI)是一种多方面的综合征,发生在不同的环境中。AKI 的病程可能多种多样,从单次打击和完全恢复,到多次打击导致终末期肾病。目前还没有开发出改善已确诊 AKI 结局的干预措施,因此预防和早期诊断是关键。开展宣传活动和对卫生保健专业人员进行关于 AKI 的诊断和管理的教育,注意避免容量不足、低血压和肾毒性干预,结合电子预警系统(如有的话),可以改善结局。基于生物标志物的策略并未显示出改善结局。液体管理应旨在早期快速恢复循环血量,但在最初的 24-48 小时后应更加有限,以避免容量超负荷。平衡晶体溶液与生理盐水的使用仍存在争议。只有在符合硬性标准的基础上才应开始进行肾脏替代治疗,但在符合标准时不应延迟。基于最近的证据,许多情况下可能高估了造影剂引起的 AKI 的风险。